Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine
Dagsetning
Höfundar
Journal Title
Journal ISSN
Volume Title
Útgefandi
Útdráttur
The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID-19. This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID-19.
Lýsing
Funding Information: Funding was provided from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine and institutional and/or departmental sources. Publisher Copyright: © 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.
Efnisorð
Anesthesiology, COVID-19, Critical Care, Humans, Societies, Medical, World Health Organization, therapeutics, AGREE II, clinical practice guideline, WHO, Anesthesiology and Pain Medicine, SDG 3 - Good Health and Well-being
Citation
Møller, M H, Chew, M S, Olkkola, K T, Rehn, M, Yli-Hankala, A & Sigurðsson, M I 2022, 'Therapeutics and COVID-19-A living WHO guideline : Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine', Acta Anaesthesiologica Scandinavica, vol. 66, no. 5, pp. 636-637. https://doi.org/10.1111/aas.14046